Form 4: KORU Medical Systems CFO Thomas Adams Reports Acquisition of Restricted Stock Units and Stock Options

Chief Financial Officer of KORU Medical Systems, Thomas Edward Adams, reports the acquisition of restricted stock units and stock options.

Summary

• Thomas Edward Adams, the CFO of KORU Medical Systems, filed a Form 4 on September 20, 2024, reporting transactions that occurred on August 15, 2024.
• The transactions involve the acquisition of restricted stock units and options to buy common stock.
• Adams acquired 21,617 restricted stock units that vest in installments starting March 15, 2025, with full vesting upon a change in control of the company.
• He also acquired 21,617 performance-based restricted stock units that vest based on performance conditions as of December 31, 2026, and fully vest upon a change in control before that date.
• Additionally, Adams acquired options to buy 47,722 shares of common stock at an exercise price of $2.35, vesting in installments starting March 15, 2025, and expiring on August 15, 2034.
• Following these transactions, Adams directly owns 21,617 restricted stock units and options to buy 47,722 shares of common stock.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, indicating routine insider transactions. The sentiment is neutral as it reflects standard compensation practices.

Positives

• The acquisition of restricted stock units and stock options by the CFO aligns his interests with those of the shareholders.
• The vesting schedules for the restricted stock units and stock options incentivize long-term performance and commitment to the company.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's securities.

Stakeholder Impact

• The reported transactions may have a minor positive impact on shareholder sentiment as they demonstrate the CFO's commitment to the company's long-term success.

Key Dates